ScholarIQanswers from OpenAlex

Regulated cell death (RCD) in cancer: key pathways and targeted therapies

PaperCitations, authors & open-access status

Regulated cell death (RCD) in cancer: key pathways and targeted therapies is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Regulated cell death (RCD) in cancer: key pathways and targeted therapies have?

ScholarIQcitation count

Regulated cell death (RCD) in cancer: key pathways and targeted therapies has 809 citations in the OpenAlex counts ScholarIQ stores.

When was Regulated cell death (RCD) in cancer: key pathways and targeted therapies published?

ScholarIQyear

Regulated cell death (RCD) in cancer: key pathways and targeted therapies has 2022 year in the ScholarIQ index.

What is the open-access status of Regulated cell death (RCD) in cancer: key pathways and targeted therapies?

ScholarIQoa status

Regulated cell death (RCD) in cancer: key pathways and targeted therapies has gold oa status in the ScholarIQ index.

What is the DOI of Regulated cell death (RCD) in cancer: key pathways and targeted therapies?

ScholarIQdoi

The DOI for Regulated cell death (RCD) in cancer: key pathways and targeted therapies is on the source record.

What is the PMID of Regulated cell death (RCD) in cancer: key pathways and targeted therapies?

ScholarIQpmid

The PMID for Regulated cell death (RCD) in cancer: key pathways and targeted therapies is on the source record.

What is the OpenAlex record for Regulated cell death (RCD) in cancer: key pathways and targeted therapies?

ScholarIQopenalex

The OpenAlex for Regulated cell death (RCD) in cancer: key pathways and targeted therapies is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial